MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    The differential transcriptomic signatures of substantia nigra in Parkinson disease and Multiple system atrophy

    JH. Shin, KE. Ruhno, C. Shin, HJ. Kim, JH. Moon, HJ. Kim (Seoul, Republic of Korea)

    Objective: To investigate transcriptomic signatures of Parkinson's disease (PD) and the Parkinsonian subtype of Multiple System Atrophy (MSA-P) in the substantia nigra pars compacta (SNpc).…
  • 2025 International Congress

    A novel potential imaging biomarker for Parkinson’s disease: Optical Coherence Tomography.

    G. Napoli, R. Santangelo, G. Rugarli, R. Balestrino, E. Sarasso, L. Ferini-Strambi, M. Filippi, F. Agosta (Milan, Italy)

    Objective: This observational cross-sectional study aims to explore the thickness of retinal layers in patients within the PD continuum, patients with isolated REM Sleep Behavior…
  • 2025 International Congress

    Genotypic and phenotypic characterization of the population living with Parkinson disease in the northwest region of Argentina

    C. Avila, G. Alvarado, L. Rojas-Vazquez, J. Diaz-Rearte, E. Franchello (San Miguel de Tucuman, Argentina)

    Objective: To conduct a demographic, phenotypic, and genotypic characterization of Parkinson's disease (PD) patients in northwest Argentina. Background: Despite PD's widespread nature, most genetic studies…
  • 2025 International Congress

    Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry

    A. Rincon, C. Pantoja, J. Torres, C. Tamayo, D. Rosselli (Bogotá, Colombia)

    Objective: Conduct a descriptive analysis of the Colombian Parkinson’s disease population and its comorbidities using data from the Colombian Ministry of Health.Estimate the prevalence and…
  • 2025 International Congress

    Evaluating the Efficacy of Virtual Reality Simulations in Enhancing Balance Recovery Among Older Adults: A Systematic Review Using Statistical Modeling

    M. Ali, N. Bekhit, F. Sakr, A. Hafez, M. Mohamed, O. Awadalla, A. Nagah, M. M. Elsayed (Mansoura, Egypt)

    Objective: To systematically evaluate the effectiveness of virtual reality (VR) simulations in enhancing balance recovery among older adults through statistical modeling. Background: Age-related declines in…
  • 2025 International Congress

    Continuous Subcutaneous Dopaminergic Stimulation: Exploring the impact of Foslevodopa/Foscarbidopa on Gait in Parkinson’s disease.

    C. O'Keeffe, J. Inocentes, M. Bradley, A. Gallagher, F. Ruggieri, R. Walsh, T. Lynch, R. Reilly, C. Fearon (Dublin, Ireland)

    Objective: The primary objective of this study is to investigate the effect of continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (FL/FC) on gait in those with…
  • 2025 International Congress

    Sensory-motor striatum iron accumulation in patients with isolated rapid eye movement sleep behavior disorder and its correlation with processing speed performance

    C. Garcia-Vicente, I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, C. Junqué, A. Iranzo, B. Segura (Madrid, Spain)

    Objective: This study aims to examine iron deposition in striatum and substantia nigra pars compacta (SNc) functionally segmented in patients with isolated rapid eye movement…
  • 2025 International Congress

    Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion

    A. Zhao, Y. Jiao, J. Liu, Y. Li (shanghai, China)

    Objective: DJ-1, also known as Parkinson's disease protein 7 (PARK7), is a multifunctional protein that is important in regulating oxidative stress and neuroprotection. Background: The…
  • 2025 International Congress

    Seasonal Variations in Emergency Department Admissions Among Parkinson’s Disease Patients: A North-South Comparative Analysis

    S. Vallamkonda, C. Wiedner, B. Westbrook, N. Kakos, C. Hinds, M. Barnes, E. Madewell, M. Metcalf, R. Irvine, A. Menta, P. Bhaya, D. Petrosyan, A. Fajayan, O. Hofheinz, J. Passarelli, J. Kong, A. Benchouia, M. Muppirala, R. Bernal, J. Himali, A. Hohler, O. Vaou (San Antonio, USA)

    Objective: We aim to compare the effect of ambient temperature on Emergency Department (ED) admissions among Parkinson’s Disease (PD) patients in extreme and regular temperatures…
  • 2025 International Congress

    Mutations of the VPS13A gene in a patient with Early-Onset Parkinson’s Disease: A case report.

    H. Pacheco, V. Gómez, C. Sánchez, L. Núñez (Mexico, Mexico)

    Objective: To describe the case of a patient with early-onset Parkinson's Disease (PD) with variants of the VPS13A gene. Background: The vacuolar protein sorting 13A…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley